Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,425.55
(
-0.80%
)
US TECH 100
22,667.60
(
-1.24%
)
Dow Jones
45,605.15
(
-0.77%
)
Brent Oil
104.47
(
3.77%
)
Bitcoin
65,994.00
(
-4.06%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122815
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: stockbettor post# 8859

Saturday, 03/08/2008 6:18:57 PM

Saturday, March 08, 2008 6:18:57 PM

Post# of 19309
Talactoferrin from Agennix is a cancer drug that is being tried in sepsis, but not specifically in sepsis with DIC. It has an FDA orphan-drug designation for renal cell carcinoma.

Here’s some info from a few years ago (follow the Reply chain for additional comments): #msg-6378629.

From Agennix’s website:
http://www.agennix.com/contentpages/lactoferrinscience.htm

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today